查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2095293

神經血栓除去裝置市場－2026-2032年全球市場預測

Neurothrombectomy Devices Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，神經血栓除去裝置市場將成長至 1,281,590,000 美元，複合年成長率為 6.41%。

主要市場統計數據
基準年 2025 8.2946億美元
預計年份：2026年 8.7956億美元
預測年份 2032 1,281,590,000 美元
複合年成長率 (%) 6.41%

血栓除去裝置執行摘要

血栓除去裝置在現代血管內中風治療中發揮核心作用，能夠對因大血管閉塞導致急性缺血性腦中風的合格患者進行快速機械取栓。由於卒中仍然是全球死亡和長期殘疾的主要原因之一，因此，加快診斷、改善轉運途徑以及增加患者獲得綜合卒中中心服務的機會是醫療保健系統的首要任務。血栓摘取支架栓器、抽吸導管、球囊引導管、遠端通路導管和一體化取栓系統的臨床價值與時間緊迫的治療窗口、基於影像的患者篩選、操作者培訓以及術後護理品質密切相關。

神經血栓切除術領域的變革性變化

在血栓除去裝置領域，正經歷著從個人化、基於手術的治療模式轉變為整合式中風診療體系的結構性轉變。臨床決策正從簡單的基於時間的標準轉向基於影像學的梗塞核心、側支循環和可挽救腦組織的評估。這種轉變強化了電腦斷層血管造影術（CTA）、電腦斷層灌注造影（CTP）、磁振造影（MRI）和標準化中風評估量表在識別可能從機械取栓術中獲益的患者方面的作用。

人工智慧的累積影響

人工智慧 (AI) 透過加速檢測主要血管閉塞、自動化影像診斷以及支援快速通知中風團隊，對神經血栓切除術的工作流程產生了日益顯著的影響。 AI 驅動的影像工具可以幫助臨床醫生識別疑似血管閉塞部位、評估缺血核心和缺血半暗帶，並優先處理需要緊急處理的病例。這些應用尤其重要，因為急性缺血性腦中風中風的治療效果高度依賴時間，運作、轉運或血管造影術室啟動的任何延遲都可能影響患者的預後。

關於神經血栓除去裝置的關鍵區域見解

在北美，成熟的卒中中心認證計畫、先進的緊急應變系統、完善的保險報銷機制以及主要都會區豐富的介入神經放射學技術，都為神經取栓術的推廣提供了支持。在美國，已建立起密集的綜合卒中中心網路，並廣泛應用先進的影像技術對大血管閉塞進行分診；而在加拿大，則強調省級卒中系統和轉運方案的協調，以應對地域分散的問題。這些因素有利於及時實施機械取栓術，但遍遠地區取得以及院際轉運仍是重要的營運挑戰。

全球中風醫療保健市場關鍵群體洞察

在七國集團（G7）國家，完善的卒中指南、高超的外科手術水平、先進的影像技術以及醫療機構在血管內治療方面豐富的經驗，推動了血栓除去裝置的應用。此外，這些國家往往擁有健全的國家和區域中風品質管理計畫，能夠持續監測從轉運到影像檢查、從轉運到穿刺、再灌注成功率以及併發症結局等各個環節的治療結果。北約成員國也具備類似的優勢，擁有充足的醫療衛生系統資金和集中的卒中專科醫療服務；然而，由於醫院分佈、公共衛生投入、急救轉運覆蓋範圍以及訓練有素的介入神經放射學專家的數量等因素，各成員國之間的卒中治療可及性存在顯著差異。

主要國家神經血栓除去裝置的發展趨勢

美國仍然是神經血栓切除術領域最先進的國家之一，這得益於其完善的卒中中心網路、快速影像檢查流程以及豐富的血管內卒中治療臨床經驗。加拿大持續加強其省級主導的卒中醫療體系，重點關注長途轉運和改善主要都會區以外地區的醫療服務。墨西哥正在擴大其三級醫療機構的血栓切除術能力，但由於各地區在專科醫生數量、影像基礎設施和急救協調方面的差異，醫療服務仍然不穩定。

為行業領導者提供的實用建議

產業領導者應優先開發以實證醫學為基礎的醫療設備，重點關注手術效率、血管安全性、輸送性能以及在不同血栓成分下的表現。產品策略應與實際臨床需求相契合，例如加速首次通過時的再灌注、與先進的抽吸技術相容以及在複雜的神經血管解剖結構中易於操作。投資臨床醫師教育、以模擬為基礎的訓練和標準化的手術流程將有助於推廣應用，同時保障病人安全。

調查方法

本執行摘要採用結構化的二手研究途徑撰寫，重點在於與血栓除去裝置和急性缺血性腦中風治療相關的檢驗且有數據支持的資料資訊來源。研究架構包括對來自同儕審查的臨床文獻、中風治療指南、監管文件、衛生部門資料、醫院中風認證標準、公共衛生數據以及中風登記處（如有）的真實世界證據進行回顧。特別關注臨床應用促進因素、手術流程趨勢、區域可近性、技術演進以及醫療保健系統的發展。

結論

神經血栓切除血栓除去裝置，它能夠機械有效地清除主要血管閉塞，而及時的診斷、恰當的患者篩選以及協調的急性缺血性腦中風護理體系則為其提供了支持。該領域的發展得益於裝置的改進、影像工作流程的最佳化、人工智慧輔助的分診以及血栓切除術響應網路的進一步擴展。成熟的醫療體系擁有完善的基礎設施和充足的專家數量，而新興地區則透過擴大三級醫療機構、開展培訓計畫以及改進急救醫療路線來提升自身能力。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 神經血栓除去裝置市場：依器械類型分類

  • 吸痰管
    • 中間內徑
    • 大直徑
  • 複合系統
    • 整合系統
    • 獨立輔助設備
  • 血栓摘取支架
    • 塗層
    • 無塗層

第8章：神經血栓除去裝置市場：依手術類型分類

  • 抽吸血栓切除手術
  • 綜合方法
    • 順序法
    • 同時執法
  • 機械血栓切除術

第9章：神經血栓除去裝置市場：以入路方式分類

  • 經股動脈路徑
  • 橈動脈入路
  • 經肱動脈入路
  • 直接頸動脈通路

第10章：神經血栓除去裝置市場：依應用領域分類

  • 急性缺血性腦中風
  • 腦靜脈血栓症
  • 腦動脈瘤血栓症
  • 動靜脈畸形（AVM）和瘻管
  • 顱內阻塞性疾病

第11章：神經血栓除去裝置市場：按分銷管道分類

  • 直銷
  • 電子商務
  • 第三方經銷商
    • 獨立銷售代理
    • 加值銷售代理

第12章：神經血栓除去裝置市場：按地區分類

  • 亞太地區
  • 歐洲
  • 北美洲
  • 拉丁美洲
  • 非洲
  • 中東

第13章：神經血栓除去裝置市場：依組別分類

  • NATO
  • G7
  • BRICS
  • EU
  • ASEAN
  • GCC

第14章 神經血栓除去裝置市場：依國家分類

  • 中國
  • 美國
  • 日本
  • 印度
  • 德國
  • 英國
  • 澳洲
  • 法國
  • 韓國
  • 義大利
  • 加拿大
  • 俄羅斯
  • 巴西
  • 墨西哥
  • 西班牙

第15章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Acandis GmbH
  • Argon Medical Devices, Inc.
  • Imperative Care
  • iVascular SLU
  • Johnson & Johnson MedTech, Inc.
  • Kaneka Corporation
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • NeuroVasc Technologies, Inc.
  • Penumbra, Inc.
  • Perflow Medical Ltd.
  • Rapid Medical
  • Route 92 Medical
  • Stryker Corporation
  • Terumo Corporation
  • VESALIO
  • Wallaby Medical Holding, Inc.
Product Code: MRR-8C74ADFC1598

The Neurothrombectomy Devices Market is projected to grow by USD 1,281.59 million at a CAGR of 6.41% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 829.46 million
Estimated Year [2026] USD 879.56 million
Forecast Year [2032] USD 1,281.59 million
CAGR (%) 6.41%

Neurothrombectomy Devices Executive Summary

Neurothrombectomy devices are central to modern endovascular stroke intervention, enabling rapid mechanical clot retrieval in eligible patients with acute ischemic stroke caused by large vessel occlusion. As stroke remains a leading cause of death and long-term disability worldwide, healthcare systems are prioritizing faster diagnosis, improved transfer pathways, and broader access to comprehensive stroke centers. The clinical value of stent retrievers, aspiration catheters, balloon guide catheters, distal access catheters, and integrated thrombectomy systems is closely tied to time-sensitive treatment windows, imaging-based patient selection, operator training, and post-procedure care quality.

The neurothrombectomy devices landscape is shaped by evidence-based stroke protocols, expanding use of advanced neuroimaging, and ongoing efforts to reduce delays from symptom onset to reperfusion. Demand is influenced by the rising burden of hypertension, diabetes, atrial fibrillation, aging populations, and lifestyle-related vascular risk factors, all of which are recognized contributors to ischemic stroke. At the same time, clinical adoption depends on reimbursement frameworks, regulatory approval pathways, neurointerventional workforce availability, hospital infrastructure, and emergency medical services coordination. For stakeholders, the most important growth enablers are not only device performance but also system-level readiness, including stroke network design, data-driven triage, and equitable patient access.

Transformative Shifts in the Neurothrombectomy Landscape

The neurothrombectomy devices landscape is undergoing a structural shift from isolated procedure-based adoption toward integrated stroke systems of care. Clinical practice has moved beyond simple time-based decision-making toward imaging-supported assessment of infarct core, collateral circulation, and salvageable brain tissue. This transition is strengthening the role of computed tomography angiography, computed tomography perfusion, magnetic resonance imaging, and standardized stroke scales in identifying patients who may benefit from mechanical thrombectomy.

Device innovation is also transforming procedural strategies. Larger-bore aspiration catheters, improved trackability, combined stent retriever and aspiration techniques, and refined access systems are supporting faster clot engagement and greater procedural efficiency. Hospitals are increasingly focused on first-pass reperfusion, reduced complications, and consistent performance across diverse clot types and vascular anatomies. Parallel improvements in anesthesia protocols, radial and femoral access approaches, and peri-procedural imaging are improving workflow reliability.

A second major shift is the decentralization of stroke identification through telestroke, mobile stroke units, and coordinated hub-and-spoke models. Primary stroke centers are becoming more connected to comprehensive thrombectomy-capable centers through digital image sharing, standardized transfer criteria, and pre-notification systems. This is especially important in regions with rural populations, uneven specialist distribution, and long transport times. Regulatory expectations are also becoming more rigorous, with greater emphasis on clinical evidence, device safety, post-market surveillance, and real-world performance tracking.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is increasingly influencing neurothrombectomy workflows by accelerating large vessel occlusion detection, automating imaging interpretation, and supporting faster notification of stroke teams. AI-enabled imaging tools can assist clinicians by identifying suspected vessel occlusion, estimating ischemic core and penumbra, and prioritizing urgent cases for review. These applications are particularly relevant because treatment benefit in acute ischemic stroke is highly time-dependent, and delays in diagnosis, transfer, or angiography suite activation can affect patient outcomes.

The cumulative impact of artificial intelligence extends beyond image analysis. AI-supported clinical decision tools are being used to streamline patient routing, improve door-to-puncture coordination, and enhance communication among emergency departments, radiology teams, neurologists, and neurointerventional specialists. In stroke networks, automated alerts and cloud-based image sharing can reduce fragmentation between referring hospitals and thrombectomy centers. Over time, AI may also support quality improvement by analyzing workflow bottlenecks, reperfusion outcomes, procedural timing metrics, and complication patterns.

However, responsible deployment remains essential. AI performance must be validated across scanner types, imaging protocols, patient demographics, and regional practice settings to avoid bias and inconsistent interpretation. Clinical teams continue to require human oversight, transparent algorithms, cybersecurity safeguards, and compliance with medical device regulations. The strongest opportunity lies in using AI as an augmentation layer that improves speed, standardization, and access while preserving physician-led decision-making.

Key Regional Insights for Neurothrombectomy Devices

In North America, neurothrombectomy adoption is supported by mature stroke center certification programs, advanced emergency response systems, established reimbursement structures, and high availability of neurointerventional expertise in major urban centers. The United States has a dense network of comprehensive stroke centers and widespread use of advanced imaging for large vessel occlusion triage, while Canada emphasizes coordinated provincial stroke systems and transfer protocols to address geographic dispersion. These factors support timely mechanical thrombectomy pathways, although rural access and interfacility transport remain important operational challenges.

Europe benefits from strong clinical guideline adoption, organized stroke registries, and extensive public healthcare infrastructure. Countries across Western Europe have developed robust thrombectomy pathways, while access remains more variable across parts of Eastern and Southern Europe due to differences in workforce availability, hospital infrastructure, and cross-regional transfer efficiency. European systems increasingly prioritize quality metrics, time-to-treatment reduction, and equitable access across urban and rural populations, supported by regulatory emphasis on device safety, clinical evidence, and post-market monitoring.

Asia-Pacific presents a highly diverse environment for neurothrombectomy devices. Japan, South Korea, Australia, and parts of China have advanced stroke care capabilities, strong imaging infrastructure, and growing interventional expertise. India and Southeast Asian countries are expanding access through tertiary hospital networks, training programs, and private-sector investment, but disparities remain in emergency transport, affordability, and specialist availability. Latin America is progressing through stroke network development in countries such as Brazil and Mexico, although access to thrombectomy-capable centers is concentrated in major metropolitan areas. The Middle East is strengthening specialized stroke services through hospital modernization and regional centers of excellence, particularly in Gulf countries, while Africa faces the most significant access constraints due to limited neurointerventional infrastructure, inconsistent imaging availability, and specialized workforce distribution.

Key Group Insights Across Global Stroke Care Economies

Within the G7, neurothrombectomy device adoption is reinforced by established stroke guidelines, high procedural capacity, advanced diagnostic imaging, and broad institutional experience with endovascular therapy. These countries are also more likely to maintain national or regional stroke quality programs, enabling continuous measurement of door-to-imaging, door-to-puncture, successful reperfusion, and complication outcomes. NATO countries show similar strengths where healthcare systems are well funded and specialist stroke services are concentrated, although access levels vary considerably across member states depending on hospital distribution, public health investment, emergency transport coverage, and trained neurointerventional workforce availability.

The European Union plays a significant role in standardizing regulatory oversight, clinical safety expectations, and post-market device surveillance for neurothrombectomy devices. EU member states benefit from cross-border clinical collaboration, multicenter evidence generation, and harmonized medical device requirements, while still facing country-level differences in reimbursement, stroke center density, and workforce capacity. BRICS economies are important for future clinical expansion because they combine large stroke patient populations with increasing investment in tertiary care, imaging infrastructure, and specialist training. However, affordability, regional inequality, uneven emergency transport systems, and differences between metropolitan and non-metropolitan healthcare access continue to affect timely availability of mechanical thrombectomy.

ASEAN countries are building stroke care capacity at different speeds. Singapore and Thailand have relatively advanced tertiary stroke services, while Indonesia, Vietnam, the Philippines, and other members are working to expand imaging access, interventional training, and referral networks. The GCC is distinguished by rapid hospital modernization, strong investment in specialty care, and growing use of international clinical protocols for acute stroke management. Across NATO, G7, BRICS, the European Union, ASEAN, and GCC economies, the key differentiator is not only device availability but the maturity of the entire stroke ecosystem, from public awareness and ambulance triage to imaging, transfer, intervention, rehabilitation, and outcomes tracking.

Key Country Insights for Neurothrombectomy Devices

The United States remains one of the most advanced environments for neurothrombectomy procedures, supported by comprehensive stroke center networks, rapid imaging protocols, and extensive clinical experience in endovascular stroke therapy. Canada continues to strengthen province-led stroke systems, with a focus on addressing long-distance transfers and improving access outside major urban areas. Mexico is expanding thrombectomy capability in tertiary hospitals, though access remains uneven due to regional disparities in specialist availability, imaging infrastructure, and emergency care coordination.

Brazil has growing expertise in large urban centers and an increasing focus on organized stroke pathways, while broader access is affected by differences between public and private healthcare resources. The United Kingdom benefits from national stroke planning and centralized specialist services, with continued efforts to improve 24/7 thrombectomy availability. Germany has a highly developed stroke unit network and strong neurointerventional capacity, while France emphasizes regional coordination and guideline-based stroke care. Italy and Spain have strengthened thrombectomy access through regional stroke networks, although geographic variation persists. Russia has specialized centers in major cities, but access across vast territories depends heavily on imaging availability, referral systems, transport logistics, and interventional workforce distribution.

China is rapidly expanding stroke center infrastructure and neurointerventional training, driven by a high burden of stroke and major hospital investment. India has increasing thrombectomy adoption in metropolitan tertiary centers, with ongoing challenges related to affordability, public awareness, ambulance systems, and rural access. Japan has advanced neurointerventional expertise, strong imaging penetration, and a large aging population that reinforces the need for high-quality stroke care. Australia relies on coordinated state-based stroke networks to serve dispersed populations, while South Korea combines advanced hospital infrastructure, high imaging availability, and strong specialist capacity to support mechanical thrombectomy pathways.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize evidence-driven device development focused on procedural efficiency, vessel safety, deliverability, and performance across varied clot compositions. Product strategies should align with real-world clinical needs, including faster first-pass reperfusion, compatibility with advanced aspiration techniques, and usability in complex neurovascular anatomies. Investments in clinician education, simulation-based training, and standardized procedural workflows can improve adoption while supporting patient safety.

Stakeholders should also strengthen partnerships with hospitals, stroke networks, emergency medical services, and imaging technology providers to reduce workflow delays. Supporting integrated care pathways can be as important as device innovation because thrombectomy outcomes depend on rapid recognition, accurate triage, efficient transfer, and timely intervention. In emerging markets, organizations should consider tiered access strategies, training collaborations, and infrastructure support that address affordability and workforce constraints without compromising quality.

Regulatory and clinical teams should build robust post-market evidence programs using registries, real-world data, and long-term safety monitoring. AI integration should be pursued responsibly, with validation across diverse populations and transparent clinical governance. Commercial strategies should focus on regions where stroke system readiness is improving, while medical affairs teams should provide education on guideline alignment, patient selection, complication management, and quality improvement metrics.

Research Methodology

This executive summary is developed using a structured secondary research approach focused on verified, data-backed sources relevant to neurothrombectomy devices and acute ischemic stroke care. The research framework includes review of peer-reviewed clinical literature, stroke treatment guidelines, regulatory publications, health authority documentation, hospital stroke certification criteria, public health data, and real-world evidence from stroke registries where available. Emphasis is placed on clinical adoption drivers, procedural workflow trends, regional access conditions, technology shifts, and healthcare system readiness.

The methodology applies triangulation across multiple credible source categories to ensure consistency and reduce dependence on any single data point. Clinical insights are assessed in relation to established evidence on mechanical thrombectomy for large vessel occlusion, imaging-based selection, treatment timelines, and endovascular workflow optimization. Regional and country-level interpretations are based on healthcare infrastructure, specialist availability, policy direction, stroke network maturity, and documented access challenges.

The analysis intentionally excludes market sizing, market share, and forecasting. Instead, it focuses on qualitative and evidence-aligned intelligence that supports strategic decision-making for product development, clinical adoption, regulatory planning, and regional access prioritization.

Conclusion

Neurothrombectomy devices are reshaping acute ischemic stroke treatment by enabling effective mechanical removal of large vessel occlusions when supported by timely diagnosis, appropriate patient selection, and coordinated stroke systems. The sector is advancing through device refinements, improved imaging workflows, AI-enabled triage, and broader development of thrombectomy-capable networks. While mature healthcare systems benefit from established infrastructure and specialist availability, emerging regions are building capacity through tertiary center expansion, training initiatives, and improved emergency pathways.

The most successful stakeholders will be those that view neurothrombectomy not simply as a device category but as part of a time-critical care continuum. Continued progress depends on clinical evidence, workflow integration, equitable access, responsible AI deployment, and collaboration across hospitals, emergency services, policymakers, and technology providers. As stroke systems evolve globally, neurothrombectomy devices will remain a critical component of efforts to reduce disability and improve outcomes for patients with large vessel occlusion stroke.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Neurothrombectomy Devices Market, by Device Type

  • 7.1. Introduction
  • 7.2. Aspiration Catheters
    • 7.2.1. Intermediate Bore
    • 7.2.2. Large Bore
  • 7.3. Combined Systems
    • 7.3.1. Integrated System
    • 7.3.2. Standalone Adjunct
  • 7.4. Stent Retrievers
    • 7.4.1. Coated
    • 7.4.2. Uncoated

8. Neurothrombectomy Devices Market, by Procedure Type

  • 8.1. Introduction
  • 8.2. Aspiration Thrombectomy
  • 8.3. Combined Approach
    • 8.3.1. Sequential
    • 8.3.2. Simultaneous
  • 8.4. Mechanical Thrombectomy

9. Neurothrombectomy Devices Market, by Access Route

  • 9.1. Introduction
  • 9.2. Transfemoral Access
  • 9.3. Transradial Access
  • 9.4. Transbrachial Access
  • 9.5. Direct Carotid Access

10. Neurothrombectomy Devices Market, by Application

  • 10.1. Introduction
  • 10.2. Acute Ischemic Stroke
  • 10.3. Cerebral Venous Thrombosis
  • 10.4. Cerebral Aneurysm Thrombosis
  • 10.5. Arteriovenous Malformation (AVM) & Fistulas
  • 10.6. Intracranial Occlusive Disease

11. Neurothrombectomy Devices Market, by Distribution Channel

  • 11.1. Introduction
  • 11.2. Direct Sales
  • 11.3. E Commerce
  • 11.4. Third Party Distributor
    • 11.4.1. Independent Distributor
    • 11.4.2. Value Added Distributor

12. Neurothrombectomy Devices Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. Europe
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Africa
  • 12.6. Middle East

13. Neurothrombectomy Devices Market, by Group

  • 13.1. NATO
  • 13.2. G7
  • 13.3. BRICS
  • 13.4. European Union
  • 13.5. ASEAN
  • 13.6. GCC

14. Neurothrombectomy Devices Market, by Country

  • 14.1. China
  • 14.2. United States
  • 14.3. Japan
  • 14.4. India
  • 14.5. Germany
  • 14.6. United Kingdom
  • 14.7. Australia
  • 14.8. France
  • 14.9. South Korea
  • 14.10. Italy
  • 14.11. Canada
  • 14.12. Russia
  • 14.13. Brazil
  • 14.14. Mexico
  • 14.15. Spain

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. FPNV Positioning Matrix, 2025
  • 15.3. Market Concentration Analysis, 2025
    • 15.3.1. Concentration Ratio (CR)
    • 15.3.2. Herfindahl Hirschman Index (HHI)
  • 15.4. Recent Developments & Impact Analysis, 2025
  • 15.5. Product Portfolio Analysis, 2025
  • 15.6. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Acandis GmbH
  • 16.2. Argon Medical Devices, Inc.
  • 16.3. Imperative Care
  • 16.4. iVascular S.L.U.
  • 16.5. Johnson & Johnson MedTech, Inc.
  • 16.6. Kaneka Corporation
  • 16.7. Medtronic plc
  • 16.8. Merit Medical Systems, Inc.
  • 16.9. MicroPort Scientific Corporation
  • 16.10. NeuroVasc Technologies, Inc.
  • 16.11. Penumbra, Inc.
  • 16.12. Perflow Medical Ltd.
  • 16.13. Rapid Medical
  • 16.14. Route 92 Medical
  • 16.15. Stryker Corporation
  • 16.16. Terumo Corporation
  • 16.17. VESALIO
  • 16.18. Wallaby Medical Holding, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ACCESS ROUTE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ACCESS ROUTE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 23. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ASPIRATION CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ASPIRATION CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ASPIRATION CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTERMEDIATE BORE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INTERMEDIATE BORE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTERMEDIATE BORE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LARGE BORE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LARGE BORE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LARGE BORE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL COMBINED SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL COMBINED SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL COMBINED SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INTEGRATED SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTEGRATED SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INTEGRATED SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL STANDALONE ADJUNCT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL STANDALONE ADJUNCT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL STANDALONE ADJUNCT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL STENT RETRIEVERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL STENT RETRIEVERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL STENT RETRIEVERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL COATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL COATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL COATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL UNCOATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL UNCOATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL UNCOATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ASPIRATION THROMBECTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ASPIRATION THROMBECTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ASPIRATION THROMBECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL COMBINED APPROACH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL COMBINED APPROACH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL COMBINED APPROACH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SEQUENTIAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SEQUENTIAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SEQUENTIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SIMULTANEOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SIMULTANEOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SIMULTANEOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MECHANICAL THROMBECTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MECHANICAL THROMBECTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MECHANICAL THROMBECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL TRANSFEMORAL ACCESS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL TRANSFEMORAL ACCESS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL TRANSFEMORAL ACCESS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL TRANSRADIAL ACCESS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL TRANSRADIAL ACCESS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL TRANSRADIAL ACCESS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL TRANSBRACHIAL ACCESS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL TRANSBRACHIAL ACCESS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL TRANSBRACHIAL ACCESS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DIRECT CAROTID ACCESS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DIRECT CAROTID ACCESS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DIRECT CAROTID ACCESS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ACUTE ISCHEMIC STROKE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ACUTE ISCHEMIC STROKE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ACUTE ISCHEMIC STROKE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CEREBRAL VENOUS THROMBOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CEREBRAL VENOUS THROMBOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CEREBRAL VENOUS THROMBOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CEREBRAL ANEURYSM THROMBOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CEREBRAL ANEURYSM THROMBOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CEREBRAL ANEURYSM THROMBOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ARTERIOVENOUS MALFORMATION (AVM) & FISTULAS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ARTERIOVENOUS MALFORMATION (AVM) & FISTULAS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ARTERIOVENOUS MALFORMATION (AVM) & FISTULAS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTRACRANIAL OCCLUSIVE DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL INTRACRANIAL OCCLUSIVE DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTRACRANIAL OCCLUSIVE DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL E COMMERCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL E COMMERCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL E COMMERCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL THIRD PARTY DISTRIBUTOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL THIRD PARTY DISTRIBUTOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL THIRD PARTY DISTRIBUTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL INDEPENDENT DISTRIBUTOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL INDEPENDENT DISTRIBUTOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL INDEPENDENT DISTRIBUTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL VALUE ADDED DISTRIBUTOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL VALUE ADDED DISTRIBUTOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL VALUE ADDED DISTRIBUTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. NATO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. NATO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. NATO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 163. NATO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 164. NATO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 165. NATO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. NATO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 167. NATO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 168. NATO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. NATO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 170. NATO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 171. G7 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. G7 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. G7 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 174. G7 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 175. G7 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 176. G7 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. G7 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 178. G7 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 179. G7 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. G7 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 181. G7 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 215. GCC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 216. GCC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. GCC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 218. GCC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 219. GCC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 220. GCC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. GCC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 222. GCC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 223. GCC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. GCC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 225. GCC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 226. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 249. JAPAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 250. JAPAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. JAPAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 252. JAPAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 253. JAPAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 254. JAPAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. JAPAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 256. JAPAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 257. JAPAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 258. JAPAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 259. JAPAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 260. INDIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 261. INDIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. INDIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 263. INDIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 264. INDIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 265. INDIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. INDIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 267. INDIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 268. INDIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 269. INDIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 270. INDIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 271. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 272. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 274. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 275. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 276. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 278. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 279. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 280. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 281. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED KINGDOM NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED KINGDOM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED KINGDOM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED KINGDOM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED KINGDOM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED KINGDOM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED KINGDOM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED KINGDOM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED KINGDOM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED KINGDOM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED KINGDOM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 293. AUSTRALIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 294. AUSTRALIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. AUSTRALIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 296. AUSTRALIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 297. AUSTRALIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 298. AUSTRALIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. AUSTRALIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 300. AUSTRALIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 301. AUSTRALIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 302. AUSTRALIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 303. AUSTRALIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 304. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 305. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 306. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 307. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 308. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 309. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 310. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 311. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 312. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 313. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 314. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 315. SOUTH KOREA NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 316. SOUTH KOREA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 317. SOUTH KOREA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 318. SOUTH KOREA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 319. SOUTH KOREA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 320. SOUTH KOREA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 321. SOUTH KOREA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 322. SOUTH KOREA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 323. SOUTH KOREA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 324. SOUTH KOREA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 325. SOUTH KOREA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 326. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 327. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 329. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 330. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 331. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 332. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 333. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 334. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 335. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 336. ITALY NEUROT